Characterization of the mechanism underlying stonustoxin-mediated relaxant response in the rat aorta in vitro

Biochemical Pharmacology

Volumn 63, Issue 6, 2002, Pages 1113-1118

  Sung, Julia Mei Li ^a   Low, Kerwin Siew Yang ^a   Khoo, Hoon Eng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Hypotension; K+ channel; Nitric oxide; Stonustoxin; Substance P receptor

Indexed keywords

2 AMINO 5,6 DIHYDRO 6 METHYL 4H 1,3 THIAZINE; N ACETYL TRYPTOPHAN 3,5 BIS(TRIFLUOROMETHYL)BENZYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; STONUSTOXIN; SUBSTANCE P; SUBSTANCE P ANTAGONIST; SUBSTANCE P RECEPTOR; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; RECEPTOR BINDING; RECEPTOR OCCUPANCY; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA; DRUG INTERACTIONS; ENZYME INHIBITORS; FISH VENOMS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; SUBSTANCE P; THIAZINES; TRYPTOPHAN; VASODILATION;

EID: 0037087643     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)00857-2     Document Type: Article

References (30)

1. Cardiovascular actions of venom of the stonefish Synanceja horrida
2. A review of stonefish venom and toxins
3. Purification and partial characterization of stonustoxin (lethal factor) from Synanceja horrida venom
4. Stonustoxin: A highly potent endothelium-dependent vasorelaxant in the rat
5. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone
6. Physiological roles and properties of potassium channels in arterial smooth muscle
7. Endothelium-dependent hyperpolarization of canine coronary smooth muscle
8. Nitric oxide: Physiology, pathophysiology, and pharmacology
9. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase
10. + channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide
11. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation
12. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential
13. Endothelium-derived hyperpolarizing factor(s): Updating the unknown
14. Electrical properties of smooth muscle cell membrane and neuromuscular transmission in the guinea-pig basilar artery
15. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat
16. Quinine inhibits release of tumor necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure
17. Regulation of slow calcium channels of myocardial cells and vascular smooth muscle cells by cyclic nucleotides and phosphorylation
18. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): Mechanisms of contractile depression by nitric oxide
19. Expression of the calcium-independent cytokine-inducible (iNOS) isoform of nitric oxide synthase in rat placenta
20. Up-regulation of inducible nitric oxide synthase and production of nitric oxide by the Swarm rat and human chondrosarcoma
21. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: Implications for contractile function
22. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues
23. Nitric oxide synthase isoform expression in the developing lung epithelium
24. The interleukin-1 family: 10 Years of discovery
25. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
26. Evolution of the sarafotoxin/endothelin superfamily of proteins
27. Peptides from frog skin
28. + channels
29. Vascular nitric oxide in health and disease
30. Substance P augments nitric oxide production and gene expression in murine macrophages